Neurocognition in NSCLC Patients Treated With Osimertinib or Osimertinib + WBI
NCT04829019
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
88
Enrollment
OTHER
Sponsor class
Conditions
Neurocognitive
Interventions
RADIATION:
Osimertinib and whole-brain irradiation
DRUG:
Osimertinib
Sponsor
Sun Yat-sen University